PAPMET Phase II Trial Advances Cancer Treatment Landscape

Opinion
Video

Key opinion leaders examine the Phase II PAPMET clinical trial, focusing on its design and progression-free survival outcomes.

Recent Videos
Stacey A. Cohen, MD, and Daniel H. Ahn, DO, presenting slides
Stacey A. Cohen, MD, and Daniel H. Ahn, DO, presenting slides
Cesar Rodriguez, MD, and Frits van Rhee, MD, PhD
4 KOLs are featured in this panel.
4 KOLs are featured in this panel.
2 KOLs are featured in this series
Stacey A. Cohen, MD, and Daniel H. Ahn, DO, presenting slides
Stacey A. Cohen, MD, and Daniel H. Ahn, DO, presenting slides
Cesar Rodriguez, MD, and Frits van Rhee, MD, PhD
Cesar Rodriguez, MD, and Frits van Rhee, MD, PhD
Related Content